• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过噬菌体展示技术生成并鉴定药物-靶点复合物特异性抗体,用于生物治疗药物的药代动力学分析。

Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.

机构信息

a Bio-Rad, Antibody Division , Puchheim , Germany.

出版信息

MAbs. 2019 Jan;11(1):178-190. doi: 10.1080/19420862.2018.1538723. Epub 2018 Dec 5.

DOI:10.1080/19420862.2018.1538723
PMID:30516449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343800/
Abstract

Anti-idiotypic antibodies play an important role in pre-clinical and clinical development of therapeutic antibodies, where they are used for pharmacokinetic studies and for the development of immunogenicity assays. By using an antibody phage display library in combination with guided in vitro selection against various marketed drugs, we generated antibodies that recognize the drug only when bound to its target. We have named such specificities Type 3, to distinguish them from the anti-idiotypic antibodies that specifically detect free antibody drug or total drug. We describe the generation and characterization of such reagents for the development of ligand binding assays for drug quantification. We also show how these Type 3 antibodies can be used to develop very specific and sensitive assays that avoid the bridging format. Abbreviations: BAP: bacterial alkaline phosphatase; CDR: complementarity-determining regions in VH or VL; Fab: antigen-binding fragment of an antibody; HRP: horseradish peroxidase; HuCAL®: Human Combinatorial Antibody Libraries; IgG: immunoglobulin G; LBA: ligand binding assay; LOQ: limit of quantitation; NHS: normal human serum; PK: pharmacokinetics; VH: variable region of the heavy chain of an antibody; VL: variable region of the light chain of an antibody.

摘要

抗独特型抗体在治疗性抗体的临床前和临床开发中起着重要作用,用于药代动力学研究和免疫原性检测的开发。通过使用抗体噬菌体展示文库并结合针对各种市售药物的体外导向选择,我们生成了仅在与靶标结合时识别药物的抗体。我们将这种特异性命名为 3 型,以将其与专门检测游离抗体药物或总药物的抗独特型抗体区分开来。我们描述了这些试剂的产生和特性,用于开发用于药物定量的配体结合测定法。我们还展示了如何使用这些 3 型抗体来开发非常特异和灵敏的测定法,避免桥连格式。缩写:BAP:细菌碱性磷酸酶;CDR:重链或轻链的互补决定区;Fab:抗体的抗原结合片段;HRP:辣根过氧化物酶;HuCAL®:人组合抗体文库;IgG:免疫球蛋白 G;LBA:配体结合测定法;LOQ:定量下限;NHS:正常人类血清;PK:药代动力学;VH:抗体重链的可变区;VL:抗体轻链的可变区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/2bd70a225cf9/kmab-11-01-1538723-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/06f3faf6de56/kmab-11-01-1538723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/a5250c17f911/kmab-11-01-1538723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/3a7d982e8f0b/kmab-11-01-1538723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/a038f21579ab/kmab-11-01-1538723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/24170ac39fd1/kmab-11-01-1538723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/193cdd0bbe74/kmab-11-01-1538723-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/46932a1e3cf0/kmab-11-01-1538723-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/6da7b87586fa/kmab-11-01-1538723-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/2bd70a225cf9/kmab-11-01-1538723-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/06f3faf6de56/kmab-11-01-1538723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/a5250c17f911/kmab-11-01-1538723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/3a7d982e8f0b/kmab-11-01-1538723-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/a038f21579ab/kmab-11-01-1538723-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/24170ac39fd1/kmab-11-01-1538723-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/193cdd0bbe74/kmab-11-01-1538723-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/46932a1e3cf0/kmab-11-01-1538723-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/6da7b87586fa/kmab-11-01-1538723-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ee5/6343800/2bd70a225cf9/kmab-11-01-1538723-g009.jpg

相似文献

1
Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics.通过噬菌体展示技术生成并鉴定药物-靶点复合物特异性抗体,用于生物治疗药物的药代动力学分析。
MAbs. 2019 Jan;11(1):178-190. doi: 10.1080/19420862.2018.1538723. Epub 2018 Dec 5.
2
Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.通过噬菌体展示技术分离人抗独特型抗体用于临床免疫反应检测。
J Immunol Methods. 2007 Dec 1;328(1-2):34-44. doi: 10.1016/j.jim.2007.08.008. Epub 2007 Sep 4.
3
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.通过噬菌体和核糖体展示分离高亲和力、中和性抗独特型抗体,用于免疫原性和药代动力学分析。
J Immunol Methods. 2015 Jan;416:49-58. doi: 10.1016/j.jim.2014.10.013. Epub 2014 Nov 7.
4
Recombinant Anti-idiotypic Antibodies in Ligand Binding Assays for Antibody Drug Development.用于抗体药物开发的配体结合分析中的重组抗独特型抗体。
Methods Mol Biol. 2021;2261:291-306. doi: 10.1007/978-1-0716-1186-9_18.
5
The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.人源组合抗体文库HuCAL GOLD将基于天然免疫系统的所有六个互补决定区(CDR)的多样化与一种用于高效筛选高亲和力抗体的新型展示方法结合在一起。
J Mol Biol. 2008 Feb 29;376(4):1182-200. doi: 10.1016/j.jmb.2007.12.018. Epub 2007 Dec 15.
6
The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective.用于全人源抗感染药物药代动力学分析的抗独特型抗体的分子工程
PLoS One. 2015 Dec 23;10(12):e0145381. doi: 10.1371/journal.pone.0145381. eCollection 2015.
7
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.噬菌体展示技术及杂交瘤技术制备抗人CXCR2抗体,所获抗体具有不同作用机制和表位。
MAbs. 2014;6(6):1425-38. doi: 10.4161/mabs.34376.
8
A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).用于高效发现抗人CXC趋化因子受体2(CXCR2)功能性单克隆抗体的体外技术组合。
MAbs. 2014;6(6):1415-24. doi: 10.4161/mabs.36237.
9
Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodies.利用内影像抗独特型抗体通过噬菌体展示分离对细胞表面抗原有特异性的单链抗体片段
J Immunol Methods. 1998 Sep 1;218(1-2):53-61. doi: 10.1016/s0022-1759(98)00115-x.
10
Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.多反应性α型抗独特型抗体与 B 细胞的非经典结合。
Mol Immunol. 2010 Nov-Dec;48(1-3):98-108. doi: 10.1016/j.molimm.2010.09.006. Epub 2010 Oct 16.

引用本文的文献

1
Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generation.先锋:一个用于快速生成治疗性先导物的合成人抗体噬菌体展示文库。
MAbs. 2025 Dec;17(1):2543769. doi: 10.1080/19420862.2025.2543769. Epub 2025 Aug 14.
2
Quantitative detection of the HVEM-BTLA checkpoint receptor cis-complex in human lymphocytes.人淋巴细胞中HVEM - BTLA检查点受体顺式复合物的定量检测。
J Immunol. 2025 Mar 1;214(3):565-572. doi: 10.1093/jimmun/vkae057.
3
Single-Stranded Variable Fragment Gene Libraries Built for Phage Display: An Updated Review of Design, Selection and Application.

本文引用的文献

1
Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum.开发并验证一种新型半均相临床检测法,用于定量检测人血清中的雷珠单抗。
J Immunol Methods. 2018 Oct;461:44-52. doi: 10.1016/j.jim.2018.05.007. Epub 2018 May 14.
2
Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments.带有荧光检测系统的分析型超速离心法揭示了重组人肿瘤坏死因子(TNF)与不同生物性TNF拮抗剂在不同环境中形成复合物的差异。
MAbs. 2017 May/Jun;9(4):664-679. doi: 10.1080/19420862.2017.1297909. Epub 2017 Mar 3.
3
用于噬菌体展示的单链可变区片段基因文库:设计、筛选与应用的最新综述
J Microbiol Biotechnol. 2024 Oct 24;35:e2407049. doi: 10.4014/jmb.2407.07049.
4
Recombinant Anti-idiotypic Antibodies in Ligand Binding Assays for Antibody Drug Development.用于抗体药物开发的配体结合分析中的重组抗独特型抗体。
Methods Mol Biol. 2021;2261:291-306. doi: 10.1007/978-1-0716-1186-9_18.
5
Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology.通过兔单 B 细胞分选培养和克隆技术快速鉴定具有高亲和力和多样化表位的抗独特型 mAbs。
PLoS One. 2020 Dec 21;15(12):e0244158. doi: 10.1371/journal.pone.0244158. eCollection 2020.
6
Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies.酶联免疫吸附试验(ELISA)方法的开发及其在 IgE 抗药物抗体灵敏和特异性检测中的应用。
AAPS J. 2020 Jan 29;22(2):36. doi: 10.1208/s12248-020-0413-z.
Ligand-Binding Assay Development: What Do You Want to Measure Versus What You Are Measuring?
配体结合分析方法的开发:你想测量的与你正在测量的是什么?
AAPS J. 2016 Mar;18(2):287-9. doi: 10.1208/s12248-015-9855-0. Epub 2015 Dec 15.
4
Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform.在药代动力学评估中,游离型与总治疗性单克隆抗体的测量受亲和力、孵育时间和生物分析平台的调节。
AAPS J. 2015 Nov;17(6):1446-54. doi: 10.1208/s12248-015-9807-8. Epub 2015 Aug 12.
5
The therapeutic monoclonal antibody market.治疗性单克隆抗体市场。
MAbs. 2015;7(1):9-14. doi: 10.4161/19420862.2015.989042.
6
Isolation of high-affinity, neutralizing anti-idiotype antibodies by phage and ribosome display for application in immunogenicity and pharmacokinetic analyses.通过噬菌体和核糖体展示分离高亲和力、中和性抗独特型抗体,用于免疫原性和药代动力学分析。
J Immunol Methods. 2015 Jan;416:49-58. doi: 10.1016/j.jim.2014.10.013. Epub 2014 Nov 7.
7
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease.阿达木单抗药物和抗体水平可预测克罗恩病患者的临床和实验室应答。
Aliment Pharmacol Ther. 2014 Sep;40(6):620-8. doi: 10.1111/apt.12869. Epub 2014 Jul 15.
8
Development of assay for determining free IgE levels in serum from patients treated with omalizumab.开发用于测定奥马珠单抗治疗患者血清中游离 IgE 水平的检测方法。
Allergol Int. 2014 May;63 Suppl 1:37-47. doi: 10.2332/allergolint.13-OA-0643.
9
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma.一种用于治疗严重难治性哮喘的新型IgE中和抗体。
MAbs. 2014 May-Jun;6(3):756-64. doi: 10.4161/mabs.28394. Epub 2014 Feb 28.
10
High-affinity recombinant antibody fragments (Fabs) can be applied in peptide enrichment immuno-MRM assays.高亲和力重组抗体片段(Fabs)可应用于肽富集免疫MRM分析。
J Proteome Res. 2014 Apr 4;13(4):2187-96. doi: 10.1021/pr4009404. Epub 2014 Mar 6.